Jianjun Jiang1, Lecong Li2, Yang Liu1, Juchao Ren3, Qingbo Su1, Sanyuan Hu1, Xiangjiu Ding4. 1. Department of Vascular Surgery, Qilu Hospital, Shandong University, Jinan, People's Republic of China. 2. Department of Intervention, Central People's Hospital of Tengzhou, Tengzhou, People's Republic of China. 3. Department of Urology, Qilu Hospital, Shandong University, Jinan, People's Republic of China. 4. Department of Vascular Surgery, Qilu Hospital, Shandong University, Jinan, People's Republic of China. Electronic address: xiangjiu-ding@sdu.edu.cn.
Abstract
OBJECTIVE: This study aimed to assess the outcomes of patients with spontaneous renal artery dissection (SRAD) after endovascular repair. METHODS: We performed a retrospective review of SRAD patients after endovascular treatment between January 2007 and August 2018. Demographic, clinical, ancillary testing, treatment, and outcome data were collected and analyzed. RESULTS: Fourteen patients (12 men and 2 women) with a mean age of 47 years were included in this study. All the patients had hypertension, either new onset (78.6%) or pre-existent (21.4%). Sudden flank pain was the most common symptom. Fourteen patients had 15 affected renal arteries. Endovascular repair was successfully performed in 14 arteries. The technical success rate of endovascular repair was 93.3% (14/15), with no postoperative death. Endovascular repair significantly improved hypertension and renal function, and these improvements persisted during the follow-up period. The effective rate of endovascular repair for improving or curing hypertension was 85.7%. Follow-up imaging showed no sign of stent stenosis or occlusion in those patients who received endovascular repair. CONCLUSIONS: Endovascular repair is safe, feasible, and effective for SRAD treatment and should be a promising alternative to open revascularization.
OBJECTIVE: This study aimed to assess the outcomes of patients with spontaneous renal artery dissection (SRAD) after endovascular repair. METHODS: We performed a retrospective review of SRAD patients after endovascular treatment between January 2007 and August 2018. Demographic, clinical, ancillary testing, treatment, and outcome data were collected and analyzed. RESULTS: Fourteen patients (12 men and 2 women) with a mean age of 47 years were included in this study. All the patients had hypertension, either new onset (78.6%) or pre-existent (21.4%). Sudden flank pain was the most common symptom. Fourteen patients had 15 affected renal arteries. Endovascular repair was successfully performed in 14 arteries. The technical success rate of endovascular repair was 93.3% (14/15), with no postoperative death. Endovascular repair significantly improved hypertension and renal function, and these improvements persisted during the follow-up period. The effective rate of endovascular repair for improving or curing hypertension was 85.7%. Follow-up imaging showed no sign of stent stenosis or occlusion in those patients who received endovascular repair. CONCLUSIONS: Endovascular repair is safe, feasible, and effective for SRAD treatment and should be a promising alternative to open revascularization.
Authors: Andrew B Dicks; Islam Y Elgendy; Vikas Thondapu; Brian Ghoshhajra; Harold D Waller; Manolo Rubio; Robert M Schainfeld; Ido Weinberg Journal: J Nephrol Date: 2022-09-30 Impact factor: 4.393